The mechanism by which amino acids increase the cellular levels of orotic acid (OA) was investigated. Administration ofglycine (2.5 mmoles/100 g) to rats resulted in a 100-fold increase in urinary OA excretion, which was inhibited by pretreatment with cycloheximide or actinomycin D. The induction of OA synthesis from NH,Cl but not from carbamoylaspartate (CA) was inhibited by cycloheximide, indicating that the cycloheximide sensitive step was after the formation of ammonia and before the formation of CA. The glycine-stimulated OA synthesis was not inhibited by acivicin, a potent inhibitor of the cytosolic carbamoylphosphate (CP) synthctase, implicating the mitochondria1 CP synthetase in supplying the CP for OA synthesis. Preliminary results indicated that cycloheximide did not inhibit glycine-induced urea synthesis to any significant extent. The results thus suggest that (i) the increased OA synthesis induced by glycine requires a transcription-translation dependent step and (ii) the regulatory step may be the transport of mitochondria1 CP to cytosol and/or the synthesis of cytosolic CA. Attempts to determine whether increased exposure of urinary bladder to high concentrations of OA will influence bladder tumorigenesis revealed that chronic administration ofglycine (2.5 mmoles/lOO g, ip, daily, 5 days a week for 20 weeks) resulted in a 44% increased incidence of hyperplastic, preneoplastic, and neoplastic lesions. Some of these rats also exhibited stones in urinary bladders. The mechanism by which glycine induces tumorigenesis in the urinary bladder is currently being explored. at SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from Vol. 15, No. 2, 1987 OROTIC ACIDURTA AND BLADDER TUMORS 195 40r 32 Actinomycin D i-glycine Cycloheximide -I-glycine c B Ln
-Rats were injected ip with 0.9% NaCl or 0.9% NaCl containing glycine (2.5 mmolesll00 9). Rats were pretreated with either actinomycin D (75 pg/kg, ip) or with cycloheximide (1.5 mg/kg, ip) 2 hr or 30 min respectively prior to the administration of glycine. Values are the average of 6 rats f SE. the start of the experiment. All experiments were started between 8 A.M. and 10 A.M. Glycine (Sigma Chemicals, St. Louis, Mo.) was prepared as a 2.5 M solution in 0.9% NaCl, Cycloheximide and actinomycin D were obtained from Boehringer Mannheim, Dorval, Quebec, Canada. Rats were housed in stainless steel metabolic cages and urine was collected for a period of 6, 12, or 24 hr after glycine administration. Rats had free access to food and water during the period of urine collection. OA was estimated by the method of Adachi et al (1) .
In chronic experiments, male Fischer 344 rats weighing 150 g were injected with sterile glycine between 10 A.M. and noon. At the time of sacrifice, the urinary bladders were fixed by inflation and immersion in 10% phosphate buffered formalin (pH 7.4). After fixation, the bladders were cut sagittally and each half was divided into four to six strips and 
RESULTS AND DISCUSSION
Administration of glycine increased the urinary excretion of OA 100 fold within 6 hr, as shown in Fig. 1 . This observation is in agreement with published results (7) . Attempts to understand the mechanism by which glycine induces the synthesis of OA revealed that the effect is a transcriptional and translational dependent event, because pretreatment with either actinomycin D or cycloheximide inhibited the increased synthesis and excretion of OA induced by glycine ( Fig. 1 ). The inhibitory effect persisted up to 24 hr after the administration of cycloheximide (data not presented). The experiment was repeated 5 times using glycine concentrations ranging from 0.6 to 2.5 mmoles/100 g and similar patterns of inhibition with cycloheximide were obtained. In order to identify the regulatory step, the effect of cycloheximide on the synthesis of OA induced by NH,Cl and carbamoylaspartate (CA) was tested. The results presented in Table I indicate that the increased synthesis induced by NH,Cl and not by CA was inhibited by cycloheximide, suggesting the regulatory step involved was after the formation of ammonia but before the formation of CA, i.e., in the synthesis of CP or CA. Since CP can be synthesized by the mitochondrial and the cytosolic synthetases, we studied the effect of acivicin, a potent inhibitor of cytosolic CP synthetase (8) . Pretreatment with acivicin did not inhibit the increased synthesis of OA induced by glycine (Table 11 ), suggesting that perhaps the mitochondria1 CP synthetase may be involved. The fact that the increased synthesis of OA induced by glycine is sensitive to 196 VASUDEVAN ET AL TOXICOLOGIC PATHOLOGY N-(phosphonacety1)L-aspartic acid (PALA), an inhibitor of aspartyltranscarbamylase (ATCase) (1 5 ) (Table 11 ), suggests that the mitochondria1 CP is converted in the cytosol by the cytosolic aspartyl transcarbamylase (ATCase) to form CA. Interestingly, cycloheximide did not inhibit the synthesis of glycine-induced urea synthesis, suggesting that the regulatory step may be in the synthesis of CA. For example, the increased transfer of CP from mitochondria to cytosol may be the transcription/ translation mediated step. Alternatively, the increased demand for aspartic acid needed for the synthesis of CA can be the regulatory step. Yet another possibility is the enzyme ATCase. Since it has a longer half-life (2) , one has to visualize the involvement of effector molecules that can activate ATCase. The effector molecules may have a shorter half-life and may be synthesized in response to increased demand.
Since the urinary bladder of glycine-treated rats is exposed to high levels of OA, it was of interest to determine if chronic administration of glycine would modulate the urinary bladder carcinogenic process. Glycine administration (2.5 mmoles/100 g body weight, ip daily, 5 days a week for 20 weeks) resulted in a 44% inkidence of hyperplastic, preneoplastic, and neoplastic lesions in the urinary bladders (cancer 1/9; papillomas 3/9; and hyperplasia 119). Also of interest is the observation that some of these rats had bladder stones, which were tentatively identified as ammonium magnesium phosphate crystals (courtesy of Dr. P. Cheng).
The observation that administration of glycine alone induces tumorigenesis in the urinary bladder is of considerable interest and deserves serious consideration. Even ifone considers that the high levels of orotic acid, a liver tumor promoter in the urinary bladder, may promote bladder carcinogenesis, there is still the question of how glycine can initiate the process. It can be speculated that administration of glycine may create a hypomethylated state, which in turn may influence the initiation process in the urinary bladder. This speculation is based on the rationale that glycine is utilized for the synthesis of guanidoacetic acid which can trap methyl groups to yield creatinine thereby creating a hypomethylated state. It is known that hypomethylation plays a role in the initiation step ofthe liver carcinogenic process (3, 4) .
Another issue that merits consideration is the presence of stones in urinary bladders of glycine treated rats. This is an important issue because of the association of the presence of stones in the bladder and tumorigenesis of the urinary bladder in the rat.
The present study revealed that the increased syn-thesis of OA and the orotic aciduria induced by glycine is a transcription/translation dependent event. Chronic administration of glycine resulted in urinary bladder tumorigenesis. The mechanisms by which glycine induces bladder tumorigenesis and the role of OA in particular in the promotion phase of bladder carcinogenesis is being explored.
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